Showing results (361-370 of 548) with videos related to
Sort By:
Pageof 55
Thrombosis and Haemostasis|July 30, 2013
Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulationMary J Heeb, Rolf M Mesters, José A Fernández, et al.Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|December 29, 2023
A recombinant signalling-selective activated protein C that lacks anticoagulant activity is efficacious and safe in cutaneous wound preclinical modelsRuilong Zhao, Meilang Xue, Haiyan Lin, et al.Advanced Healthcare Materials|December 9, 2023
Conductive Microgel Annealed Scaffolds Enhance Myogenic Potential of Myoblastic CellsAlena Casella, Jeremy Lowen, Katherine H Griffin, et al.The Journal of Biological Chemistry|April 25, 2000
Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavageP F Marx, T M Hackeng, P E Dawson, et al.Circulation|April 3, 2001
Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic strokeM Shibata, S R Kumar, A Amar, et al.Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primatesA Gruber, J A Fernández, L Bush, et al.Journal of Animal Science|June 1, 1993
Decreased fat content and increased lean in pigs treated with antibodies to adipocyte plasma membranesS Kestin, R Kennedy, E Tonner, et al.Blood|August 8, 2015
Exacerbated venous thromboembolism in mice carrying a protein S K196E mutationFumiaki Banno, Toshiyuki Kita, José A Fernández, et al.Advanced Healthcare Materials|January 31, 2023
Multisized Photoannealable Microgels Regulate Cell Spreading, Aggregation, and Macrophage Phenotype through Microporous Void SpaceJeremy M Lowen, Gabriella C Bond, Katherine H Griffin, et al.Current Pharmaceutical Design|December 31, 2013
Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteersPatrick Lyden, Howard Levy, Sara Weymer, et al.Pageof 55